
ICU Medical, Inc. (ICUI) Q4 2025 Earnings Call Transcript
ICUI • NASDAQ
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold ICUI in your mock portfolio yet.
The negative EPS and extremely high negative P/E ratio indicate that ICU Medical is currently unprofitable, which is a clear fundamental headwind. While the share price is above the 200-day moving average (implying some market confidence), the loss-making status suggests profitability and margin issues that still need to be resolved. Without evidence of improving earnings trends, the financial picture leans negative despite any potential longer‑term recovery story.
The stock trades at $151.63, modestly below recent levels with a 2.3% decline over the last month, suggesting mild short‑term weakness but not a breakdown. Trading above the 200‑day moving average of $134.15 and an RSI of 56.27 indicate the intermediate trend is still constructive and not overbought or oversold. Overall, technicals suggest a stable to slightly positive trend, but not a strong momentum setup.
Alternative data for ICU Medical is broadly stable with modest positive signals but no strong inflection. Job openings are slightly down month over month, hinting at cautious hiring or efficiency efforts, while social media followings—especially on LinkedIn and Instagram—are growing slowly, suggesting steady brand and professional visibility. Web traffic at roughly 119k monthly visitors appears stable, providing no clear demand surge but also no sign of sharp deterioration.
ICU Medical’s stock shows technically stable to mildly positive price action, but this is offset by weak current profitability, as reflected in negative EPS and a highly negative P/E ratio. Alternative data is generally steady with modestly positive social and professional engagement, yet not strong enough to override the fundamental earnings concerns. Overall, the balance of technical resilience against loss‑making fundamentals supports a neutral stance at this time.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Key moves vs recent baseline (last day / last week)
Plain-English summary of the biggest drivers (informational)
Potential risk factors to review
Based on earnings timing, volatility, liquidity and crowd activity. Informational signals only — not investment advice.
Reassess your thesis if any of these occur: